Renal Angiomyolipoma Based on New Classification: How to Differentiate It From Renal Cell Carcinoma.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 30620673.
- Also identified by DOI 10.2214/AJR.18.20408.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The purpose of this article is to describe useful imaging features for differentiating angiomyolipoma (AML) subtypes from renal cell carcinoma subtypes. A newer radiologic classification of renal AML consists of fat-rich AML (≤ -10 HU), fat-poor AML (> -10 HU; tumor-to-spleen ratio < 0.71; signal intensity index, > 16.5%), and fat-invisible AML (> -10 HU; tumor-to-spleen ratio, > 0.71; signal intensity index, < 16.5%). Each subtype must be differentiated from the renal cell carcinoma subtype because of overlapping imaging features.
Medical subject headings
- Carcinoma, Renal Cell
- Kidney Neoplasms